Literature DB >> 18431918

[The low prevalence of Helicobacter pylori gastritis in newly diagnosed inflammatory bowel disease children and adolescent].

Małgorzata Sładek1, Urszula Jedynak-Wasowicz, Andrzej Wedrychowicz, Kinga Kowalska-Duplaga, Stanisław Pieczarkowski, Krzysztof Fyderek.   

Abstract

Data concerning prevalence rate of Helicobacter pylori gastritis in inflammatory bowel disease (IBD) patients is conflicting. We had studied the prevalence of Hp gastritis in newly diagnosed inflammatory bowel disease children before any pharmacological treatment was introduced. Ninety four consecutive children with inflammatory bowel diseased were enrolled into study, mean age 12.9 +/- 3.75 years, including 50 with Crohn's Disease (CD) and 44 with ulcerative colitis (UC). One hundred and four patients (mean age 13.6 +/- 4.2 year) referred for diagnostic evaluation because of recurrent abdominal pain, matched for age, sex and socioeconomic status served as a control. The results revealed a highly statistically lower prevalence of Hp gastritis in children with IBD as compared with controls (9.6% vs. 38.4%, p < 0.0001). Significantly more often Hp gastritis occurred in CD than UC patients. There was no statistical difference in mean age of IBD onset between Hp gastritis positive and negative groups (14.3 +/- 3.75 vs. 13.6 +/- 4.3 yr) was found. Our results show that in newly diagnosed IBD children, Hp gastritis is not unusual, but the prevalence rate is significantly lower comparing to the control group. The low Hp gastritis rate is not related to medical treatment, since the patients were studied before any was introduced.

Entities:  

Mesh:

Year:  2007        PMID: 18431918

Source DB:  PubMed          Journal:  Przegl Lek        ISSN: 0033-2240


  12 in total

1.  DC-derived IL-18 drives Treg differentiation, murine Helicobacter pylori-specific immune tolerance, and asthma protection.

Authors:  Mathias Oertli; Malin Sundquist; Iris Hitzler; Daniela B Engler; Isabelle C Arnold; Sebastian Reuter; Joachim Maxeiner; Malin Hansson; Christian Taube; Marianne Quiding-Järbrink; Anne Müller
Journal:  J Clin Invest       Date:  2012-02-06       Impact factor: 14.808

2.  Role of Helicobacter species in Chinese patients with inflammatory bowel disease.

Authors:  Shenghong Zhang; Bihui Zhong; Kang Chao; Yingliang Xiao; Yi Cui; Xiang Gao; Baili Chen; Yao He; Pinjin Hu; Minhu Chen; Hazel M Mitchell
Journal:  J Clin Microbiol       Date:  2011-02-23       Impact factor: 5.948

Review 3.  Helicobacter pylori targets dendritic cells to induce immune tolerance, promote persistence and confer protection against allergic asthma.

Authors:  Mathias Oertli; Anne Müller
Journal:  Gut Microbes       Date:  2012-08-16

Review 4.  Association between Helicobacter pylori infection and inflammatory bowel disease: a meta-analysis and systematic review of the literature.

Authors:  Jay Luther; Maneesh Dave; Peter D R Higgins; John Y Kao
Journal:  Inflamm Bowel Dis       Date:  2010-06       Impact factor: 5.325

Review 5.  Helicobacter pylori infection and inflammatory bowel disease: is there a link?

Authors:  Konstantinos Papamichael; Panagiotis Konstantopoulos; Gerassimos J Mantzaris
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

6.  The association between Helicobacter pylori infection and inflammatory bowel disease based on meta-analysis.

Authors:  T Rokkas; J P Gisbert; Y Niv; C O'Morain
Journal:  United European Gastroenterol J       Date:  2015-12       Impact factor: 4.623

7.  H. pylori exploits and manipulates innate and adaptive immune cell signaling pathways to establish persistent infection.

Authors:  Anne Müller; Mathias Oertli; Isabelle C Arnold
Journal:  Cell Commun Signal       Date:  2011-11-01       Impact factor: 5.712

8.  Colonic Abnormalities in Manitoban Children with Helicobacter pylori Gastritis.

Authors:  Upama Banik; Camelia Stefanovici; Jennifer Griffin; Wael El-Matary
Journal:  Gastroenterol Res Pract       Date:  2018-04-02       Impact factor: 2.260

Review 9.  The immunomodulatory properties of Helicobacter pylori confer protection against allergic and chronic inflammatory disorders.

Authors:  Isabelle C Arnold; Iris Hitzler; Anne Müller
Journal:  Front Cell Infect Microbiol       Date:  2012-02-16       Impact factor: 5.293

10.  Gastric lesions in patients with Crohn's disease in Korea: a multicenter study.

Authors:  Hoonsub So; Byong Duk Ye; Young Soo Park; Jihun Kim; Joo Sung Kim; Won Moon; Kang-Moon Lee; You Sun Kim; Bora Keum; Seong-Eun Kim; Kyeong Ok Kim; Eun Soo Kim; Chang Kyun Lee; Sung Pil Hong; Jong Pil Im; Ja Seol Koo; Chang Hwan Choi; Jeong Eun Shin; Bo In Lee; Kyu Chan Huh; Young-Ho Kim; Hyun-Soo Kim; Young Sook Park; Dong Soo Han
Journal:  Intest Res       Date:  2016-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.